Therapeutic and Prophylactic Vaccine Market
The world vaccine market, once characterized by slow growth, has seen increased sales as a result of new paediatric vaccines and the burgeoning influenza vaccine markets in the U.S. and Europe. You should be taking advantage of this growth NOW!!. The adult market for vaccines is predicted to grow by 26.3 per cent in 2004, but what will it be in 2007 - only It’s unique report can tell you today.
In 2003 the world vaccine market is valued at over $5 billion, shouldn’t you be claiming an increased share of this market immediately.
Paediatric vaccines still hold the largest share of the overall market, but influenza and hepatitis vaccine sales have grown significantly over the past few years. Paediatric vaccines markets are growing at a slower rate than the adult market and you need to position your company correctly to ensure your continued success.
A large number of therapeutic vaccines under development prove to make the vaccine market an interesting and dynamic one over the next five years. Therapeutic vaccines are currently being tested against cancer and are approaching approval.
The Therapeutic and Prophylactic Vaccine Market 2003 provides in-depth analysis of the vaccine market, presents key findings that are driving the market, and contains up-to-date information regarding vital clinical trials, sales figures, and profiles of key vaccine companies.
For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=44660
_______________________________________________________________